Idiopathic Hypertrophic Spinal Pachymeningitis.

Hypertrophic pachymeningitis IHSP Idiopathic Spinal cord compression Steroids

Journal

Journal of medical cases
ISSN: 1923-4163
Titre abrégé: J Med Cases
Pays: Canada
ID NLM: 101551824

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 23 08 2023
accepted: 02 11 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: ppublish

Résumé

Hypertrophic pachymeningitis (HP) is a rare presentation with duramater thickening and fibrosis which can result in cranial or spinal compressive disease. Most cases of spinal HP require surgical management. We present an uncommon case of idiopathic hypertrophic spinal pachymeningitis (IHSP) in a 40-year-old male who showed complete improvement to steroids without any further relapses. The patient presented with bilateral upper limb weakness with magnetic resonance imaging (MRI) spine showing diffuse dural thickening of the entire spine with cervical cord compression. He had an extensive workup for underlying etiology and worsening symptoms until he was diagnosed with IHSP. Later, he was started on high-dose steroids with good response and no relapse after 2 years. A descriptive analysis of IHSP cases since 2009 including ours showed that it usually occurs after 50s with female preponderance. Weakness and sensory loss are the most common complaints with 50% patients showing clinical signs of myelopathy like hyperreflexia, clonus, Babinski sign and sensory level. Cerebrospinal fluid (CSF) and inflammatory markers like erythrocytic sedimentation rate (ESR) and C-reactive protein (CRP) can be used to assess disease progression and prognosis. Surgical removal of HP followed by steroids is the best line of management while steroids alone can be tried in cases where clinical signs of myelopathy are absent.

Identifiants

pubmed: 38186557
doi: 10.14740/jmc4149
pmc: PMC10769654
doi:

Types de publication

Case Reports

Langues

eng

Pagination

405-412

Informations de copyright

Copyright 2023, Gupta et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Ashutosh Gupta (A)

McGovern Medical School, UT Health Science Center at Houston, Houston, TX 77030, USA.

Daniel Um (D)

McGovern Medical School, UT Health Science Center at Houston, Houston, TX 77030, USA.

Rohan Samant (R)

Department of Radiology, UT Health Science Center at Houston, TX 77030, USA.

Rodrigo Hasbun (R)

Department of Infectious Disease, UT Health Science Center at Houston, TX 77030, USA.

Rohini D Samudralwar (RD)

Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.

Shitiz Sriwastava (S)

Division of Multiple Sclerosis and Neuroimmunology, Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Rajesh K Gupta (RK)

Division of Multiple Sclerosis and Neuroimmunology, Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Classifications MeSH